Dosage Preparations: 100 mg single-use vial containing powder for concentrate for infusion solution designed to deliver 5 ml of 20 mg/ml of trastuzumab emtansine.
160 mg single-use vial containing powder for concentrate for infusion solution designed to deliver 8 ml of 20 mg/ml of trastuzumab emtansine.
Sterile/Radioactive Statement: Sterile product.
Excipients/Inactive Ingredients: Sodium succinate, Sucrose, Polysorbate 20.
Other Services
Country
Account